1. Home
  2. BLTE vs SPT Comparison

BLTE vs SPT Comparison

Compare BLTE & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$152.68

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

SPT

Sprout Social Inc

HOLD

Current Price

$6.77

Market Cap

327.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLTE
SPT
Founded
2018
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
327.6M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
BLTE
SPT
Price
$152.68
$6.77
Analyst Decision
Strong Buy
Buy
Analyst Count
7
8
Target Price
$198.00
$11.75
AVG Volume (30 Days)
102.1K
1.3M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.11
EPS
N/A
N/A
Revenue
N/A
$457,547,000.00
Revenue This Year
N/A
$8.86
Revenue Next Year
$492.11
$8.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.72
52 Week Low
$56.68
$4.92
52 Week High
$200.00
$24.74

Technical Indicators

Market Signals
Indicator
BLTE
SPT
Relative Strength Index (RSI) 42.18 61.28
Support Level $148.06 $6.52
Resistance Level $161.28 $7.39
Average True Range (ATR) 5.58 0.36
MACD -0.80 0.12
Stochastic Oscillator 15.51 95.51

Price Performance

Historical Comparison
BLTE
SPT

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.

Share on Social Networks: